{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "21772116",
  "DateCompleted": {
    "Year": "2011",
    "Month": "08",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "jpn"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0385-0684",
      "JournalIssue": {
        "Volume": "38",
        "Issue": "7",
        "PubDate": {
          "Year": "2011",
          "Month": "Jul"
        }
      },
      "Title": "Gan to kagaku ryoho. Cancer & chemotherapy",
      "ISOAbbreviation": "Gan To Kagaku Ryoho"
    },
    "ArticleTitle": "[Response in a case of advanced rectal cancer treated by chemoradiation with S-1/oxaliplatin].",
    "Pagination": {
      "StartPage": "1217",
      "EndPage": "1219",
      "MedlinePgn": "1217-9"
    },
    "Abstract": {
      "AbstractText": [
        "A 62-year-old male was admitted to our hospital because of anal pain and bloody stool. After careful examination, a locally advanced rectal cancer was found, and an invasion of the prostate was suspected. The prevention of pelvic recurrence and downstaging for S-1/oxaliplatin (SOX), combined with preoperative chemoradiation (CRT) make, PR decision (reduction rate 70%), and surgery (APR+central D3) were performed. The postoperative course was uneventful and the patient was discharged 18 hospital days after surgery. The outpatient is receiving the adjuvant chemotherapy by single S-1 now. Advanced lower rectal cancer S-1/oxaliplatin (SOX), combined with preoperative chemoradiation (CRT), have fewer adverse events and are considered to be useful."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dept. of Surgery, Ohta Nishinouchi Hospital, Japan."
          }
        ],
        "LastName": "Saito",
        "ForeName": "Masaru",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ishi",
        "ForeName": "Yoshimasa",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kikuchi",
        "ForeName": "Daiki",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yamada",
        "ForeName": "Mutsuo",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Takenoshita",
        "ForeName": "Seiichi",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Japan",
    "MedlineTA": "Gan To Kagaku Ryoho",
    "NlmUniqueID": "7810034",
    "ISSNLinking": "0385-0684"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Drug Combinations"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Organoplatinum Compounds"
    },
    {
      "RegistryNumber": "04ZR38536J",
      "NameOfSubstance": "Oxaliplatin"
    },
    {
      "RegistryNumber": "150863-82-4",
      "NameOfSubstance": "S 1 (combination)"
    },
    {
      "RegistryNumber": "1548R74NSZ",
      "NameOfSubstance": "Tegafur"
    },
    {
      "RegistryNumber": "5VT6420TIG",
      "NameOfSubstance": "Oxonic Acid"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biopsy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Combined Modality Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Combinations"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Staging"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Organoplatinum Compounds"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Oxaliplatin"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Oxonic Acid"
    },
    {
      "QualifierName": [
        "drug therapy",
        "pathology",
        "radiotherapy",
        "surgery"
      ],
      "DescriptorName": "Rectal Neoplasms"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Tegafur"
    }
  ]
}